Clopidogrel HCl is the salt form of a platelet aggregation inhibitor that acts by blocking ADP binding to its P2Y12 receptor. This product is widely used in cardiovascular research, including in vitro platelet function assays and in vivo models of thrombosis and atherosclerosis.